Kimiko Della Croce

1.0k total citations
15 papers, 745 citations indexed

About

Kimiko Della Croce is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Kimiko Della Croce has authored 15 papers receiving a total of 745 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Genetics. Recurrent topics in Kimiko Della Croce's work include Chronic Lymphocytic Leukemia Research (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and Retinal Development and Disorders (2 papers). Kimiko Della Croce is often cited by papers focused on Chronic Lymphocytic Leukemia Research (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and Retinal Development and Disorders (2 papers). Kimiko Della Croce collaborates with scholars based in United States, China and Netherlands. Kimiko Della Croce's co-authors include Christopher Riley, Guang Yao, Jianhua Xing, David J. Bearss, Daruka Mahadevan, John D. Prugh, R. B. Levine, Kishore Shakalya, Raymond B. Nagle and Laurence Cooke and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Blood.

In The Last Decade

Kimiko Della Croce

15 papers receiving 731 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kimiko Della Croce United States 11 291 230 177 113 90 15 745
Shigekazu Yokoyama Japan 15 712 2.4× 271 1.2× 197 1.1× 148 1.3× 30 0.3× 53 1.3k
K Toyoshima Japan 11 510 1.8× 282 1.2× 329 1.9× 66 0.6× 60 0.7× 13 1.0k
Shouyong Peng United States 18 991 3.4× 305 1.3× 53 0.3× 151 1.3× 98 1.1× 33 1.4k
Mika Sakurai‐Yageta Japan 17 798 2.7× 192 0.8× 171 1.0× 109 1.0× 42 0.5× 34 1.2k
Giuseppina Giardina Italy 13 440 1.5× 214 0.9× 317 1.8× 34 0.3× 34 0.4× 15 958
Konstantina Alexandropoulos United States 19 892 3.1× 199 0.9× 347 2.0× 33 0.3× 36 0.4× 36 1.4k
Armin Rehm Germany 23 503 1.7× 443 1.9× 615 3.5× 36 0.3× 123 1.4× 52 1.3k
Nik Matthews United Kingdom 17 1.3k 4.5× 411 1.8× 233 1.3× 183 1.6× 129 1.4× 26 1.9k
David P. Astling United States 15 591 2.0× 224 1.0× 65 0.4× 228 2.0× 95 1.1× 24 900
HoJoon Lee United States 14 402 1.4× 165 0.7× 116 0.7× 69 0.6× 97 1.1× 38 728

Countries citing papers authored by Kimiko Della Croce

Since Specialization
Citations

This map shows the geographic impact of Kimiko Della Croce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimiko Della Croce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimiko Della Croce more than expected).

Fields of papers citing papers by Kimiko Della Croce

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimiko Della Croce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimiko Della Croce. The network helps show where Kimiko Della Croce may publish in the future.

Co-authorship network of co-authors of Kimiko Della Croce

This figure shows the co-authorship network connecting the top 25 collaborators of Kimiko Della Croce. A scholar is included among the top collaborators of Kimiko Della Croce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimiko Della Croce. Kimiko Della Croce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Bi, Liu, Kimiko Della Croce, Min Wu, et al.. (2020). Curcumin derivative C212 inhibits Hsp90 andeliminates both growing and quiescent leukemia cells in deep dormancy. Cell Communication and Signaling. 18(1). 159–159. 8 indexed citations
2.
Li, Ruoyan, Hengyu Chen, Kimiko Della Croce, et al.. (2019). Graded regulation of cellular quiescence depth between proliferation and senescence by a lysosomal dimmer switch. Proceedings of the National Academy of Sciences. 116(45). 22624–22634. 91 indexed citations
3.
Tian, Xiaobo, Kimiko Della Croce, Guang Yao, et al.. (2019). Multi-wavelength quantitative polarization and phase microscope. Biomedical Optics Express. 10(4). 1638–1638. 15 indexed citations
4.
Wang, Xia, et al.. (2017). Exit from quiescence displays a memory of cell growth and division. Nature Communications. 8(1). 321–321. 40 indexed citations
5.
Wang, Xia, et al.. (2017). Controlling Depth of Cellular Quiescence by an Rb-E2F Network Switch. Cell Reports. 20(13). 3223–3235. 93 indexed citations
6.
Zhang, Wenjing, Xinli Tian, Jun Jiao, et al.. (2015). The existence of Th22, pure Th17 and Th1 cells in CIN and Cervical Cancer along with their frequency variation in different stages of cervical cancer. BMC Cancer. 15(1). 717–717. 31 indexed citations
7.
Qi, Wenqing, Christopher Riley, Kimiko Della Croce, et al.. (2009). MP470, a novel receptor tyrosine kinase inhibitor, in combination with Erlotinib inhibits the HER family/PI3K/Akt pathway and tumor growth in prostate cancer. BMC Cancer. 9(1). 142–142. 40 indexed citations
8.
Riley, Christopher, K. Engelhardt, José W. Saldanha, et al.. (2009). Design and Activity of a Murine and Humanized Anti-CEACAM6 Single-Chain Variable Fragment in the Treatment of Pancreatic Cancer. Cancer Research. 69(5). 1933–1940. 33 indexed citations
9.
Cooke, Laurence, Murray Yule, Neil T. Thompson, et al.. (2008). AT7519, a Potent Multi-Targeted CDK Inhibitor, Is Active in CLL Patient Samples Independent of Stage. Blood. 112(11). 3161–3161. 2 indexed citations
10.
Mahadevan, Daruka, Laurence Cooke, Christopher Riley, et al.. (2007). A novel tyrosine kinase switch is a mechanism of imatinib resistance in gastrointestinal stromal tumors. Oncogene. 26(27). 3909–3919. 224 indexed citations
11.
Squires, Matthew, Ruth E. Feltell, Victoria Lock, et al.. (2007). AT7519, a Potent CDK Inhibitor, Is Active in Leukemia Models and Primary CLL Patient Samples.. Blood. 110(11). 3127–3127. 2 indexed citations
12.
Mahadevan, Daruka, Kimiko Della Croce, Christopher Riley, et al.. (2006). Transcriptosome and serum cytokine profiling of an atypical case of myelodysplastic syndrome with progression to acute myelogenous leukemia. American Journal of Hematology. 81(10). 779–786. 26 indexed citations
13.
Mahadevan, Daruka, Catherine Spier, Kimiko Della Croce, et al.. (2005). Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures. Molecular Cancer Therapeutics. 4(12). 1867–1879. 73 indexed citations
14.
Saldanha, José W., et al.. (2004). A humanized anti-CEACAM6 monoclonal antibody targeting pancreatic adenocarcinoma demonstrates potent in vitro and in vivo activity.. 64. 502–502. 1 indexed citations
15.
Prugh, John D., Kimiko Della Croce, & R. B. Levine. (1992). Effects of the steroid hormone, 20-hydroxyecdysone, on the growth of neurites by identified insect motoneurons in vitro. Developmental Biology. 154(2). 331–347. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026